Dr Raquel Faria and Professor David Isenberg review selected highlights from the 16th International Congress on SLE. Join us for a groundbreaking discussion on the latest inlupus research, clinical trials, guidelines and patient reported outcomes.Disclaimer: During Lupus Academy podcast episodes, participants may refer to off-label use of medicines for patients with lupus. Lupus Academy does not make anyrecommendations about using a medicine outside the terms of its approved license for use.
--------
46:25
--------
46:25
NPSLE: Understanding the Neurological Burden in SLE
Dr Raquel Faria and Professor David Isenberg discuss the impact of neurological events in SLE including their associated mortality risk, effect on patients’ QoL, fatigue and persistent neurological impairment throughout life.Disclaimer: During Lupus Academy podcast episodes, participants may refer to off-label use of medicines for patients with lupus. Lupus Academy does not make anyrecommendations about using a medicine outside the terms of its approved license for use.
--------
42:22
--------
42:22
Cases from the Clinic: Fatal MI and Lupus Nephritis
In this episode, Dr. Raquel Faria hosts a discussion with Professors David Isenberg and Murray Urowitz from the Lupus Academy Steering Committee. They delve into two historic cases: one involving Lupus and Myocardial Infarction, and the other focusing on Lupus Nephritis.Disclaimer: During Lupus Academy podcast episodes, participants may refer to off-label use of medicines for patients with lupus. Lupus Academy does not make anyrecommendations about using a medicine outside the terms of its approved license for use.
--------
52:31
--------
52:31
From Persistent Arthritis to Jaccoud’s Arthropathy: Navigating the Treatment Paradigm.
In this episode, Dr Raquel Faria discusses a complex case with Professors Andrea Doria and Maria Dall’Era of the Lupus Academy Steering Committee. Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.
--------
54:07
--------
54:07
REGENCY: Obinutuzumab’s Promise for Lupus Nephritis
Join Dr Raquel Faria and Professors Richard Furie and Maria Dall’Era as they discuss the results of the phase 3 REGENCY trial of obinutuzumab for the treatment of lupus nephritis.This episode explores what obinutuzumab could mean for the future management of lupus nephritis. Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.
The Lupus Academy has been providing accredited education in SLE for healthcare professionals since 2012 and in this monthly podcast Raquel Faria, an Internal Medicine Consultant at the Centro Hospitalar in Porto, will talk with experts from the Lupus Academy Steering Committee about SLE highlights of congresses, we will discuss difficult cases and we have an annual episode where we review all the exciting things that have been happening in lupus that year.
Brasil